<DOC>
	<DOCNO>NCT02270853</DOCNO>
	<brief_summary>In study analyze often sleep apnea syndrome observed patient newly diagnose lung cancer help ApneaLink device ResMed .</brief_summary>
	<brief_title>SAS Patients With Bronchial Carcinoma</brief_title>
	<detailed_description>Determination SAS- frequence patient bronchial carcinoma . The patient screen home 1 night ApneaLink device ResMed . The apneaLink device standard screen tool sleep apnea clinical practice .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Carcinoma , Bronchogenic</mesh_term>
	<criteria>Patients reasonable suspicion bronchial carcinoma histologically proven bronchial carcinoma , medicate study entry Patients sleep apnea recently diagnose bronchial carcinoma . Pregnancy already know malignancy tumor Patients noninvasive artificial respiration due chronic respiratory insufficiency</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>ApneaLink</keyword>
	<keyword>bronchial carcinoma</keyword>
	<keyword>sleep apnea screen</keyword>
</DOC>